The Silhouette of Stem Cells

참고문헌 (Reference)

1 Krouse DS, "multi-lineageengraftment by a single bone marrow-derived stem cell" 105 : 369-377, 2001.

2 Li Y, "Treatment of stroke in ratwith intracarotid administration of marrow stromal cells" 56 : 1666-1672, 2001.

3 Slavin S, "Treatment of leukemia by alloreactive lymphocytes and nonmyeloablativestem cell transplantation" 22 : 64-69, 2002.

4 Horwitz ME, "Treatment of chronic granulomatous disease with nonmyeloablativeconditioning and a T-cell-depleted hematopoieticallograft" 344 : 881-888, 2001.

5 Reisner Y, "Tolerance induction by 'megadose'transplants of CD34± stem cells a new option for leukemiapatients without an HLA-matched donor" 12 : 536-541, 2000.

6 Kim DW, "Third partymesenchymal stromal cells can alleviate the one-donor predominancein mixed transplantation of two unrelated cord blood." in press

7 Ko S, "The functional relevance ofpassenger leukocytes and microchimerism for heart allograftacceptance in the rat" 5 : 1292-1297, 1999.

8 Spitzer TR, "The expanding applications of non-myeloablative stemcell transplantation" 7 : 95-100, 2003.

9 Blau HM, "The evolving concept of astem cell entity or function" 105 : 829-841, 2001.

10 Starzl TE, "Systemic chimerismin human female recipients of male livers" 876-340 877, 1992.

11 Reisner Y, "Stem cell transplantation across major genetic barriers" 938 : 322-326, 2001.

12 Nagler A, "Second allogeneicstem cell transplantation using nonmyeloablative conditioning forpatients who relapsed or developed secondary malignanciesfollowing autologous transplantation" 28 : 1096-1104, 2002.

13 Hakelien AM,, "Reprogramming fibroblasts to express T-cell functions using cellextracts" 20 : 460-466, 2002.

14 Childs R, "Regression of metastatic renal-cell carcinoma after nonmyeloablativeallogeneic peripheral-blood stem-cell transplantation" 343 : 750-758, 2000.

15 Lagasse E, "Purified hematopoietic stem cells can differentiate into hepatocytesin vivo" 6 : 1229-1234, 2000.

16 Shirwan H, "Pretransplant injection of allograft recipients with donor blood orlymphocytes permits allograft tolerance without the presence ofpersistent donor microchimerism" 61 : 1382-1386, 1996.

17 Jiang Y, "Pluripotency of mesenchymal stem cells derived form adultmarrow" 418 : 41-49, 2002.

18 van Pel M, "Permanent acceptance of both cardiac and skin allografts usinga mild conditioning regimen for the induction of stable mixedchimerism in mic" 11 : 57-63, 2003.

19 Kondo T, "Oligodendrocyte precursor cells reprogrammed tobecome multipotential CNS stem cells" 289 : 1754-1757, 2000.

20 Tada M, "Nuclearreprogramming of somatic cells by in vitro hybridization with EScells" 11 : 1553-1558, 2001.

21 Or R, "Nonmyeloablative allogeneicstem cell transplantation for the treatment of chronic myeloidleukemia in first chronic phase" 101 : 441-445, 2003.

22 Prigozhina TB, "Nonmyeloablative allogeneic bone marrow transplantation asimmunotherapy for hematologic malignancies and metastatic solidtumors in preclinical models" 30 : 89-96, 2002.

23 Kocher AA, "Neovascularization ofischemic myocardium by human bone-marrow-derived angioblastsprevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function" 7 : 430-436, 2001.

24 Pittenger MF, "Multilineage potential of adult human mesenchymal stem cells" 284 : 143-147, 1999.

25 Shen CN, "Molecular basis of transdifferentiationof pancreas to liver" 2 : 879-887, 2000.

26 Orlic D, "Mobilized bone marrow cells repair the infarcted heart, improving function and surviva" 98 : 10344-10349, 2001.

27 Nierhoff D, "Microchimerism in bone marrow-derived CD34(±) cells of patients after liver transplantation" 96 : 763-767, 2000.

28 Bartholomew A, "Mesenchymal stem cells suppress lymphocyte proliferation invitro and prolong skin graft survival in vivo." 30 : 42-48, 2002.

29 Le Blanc K, "Mesenchymal stem cells inhibit and stimulate mixed lymphocytecultures and mitogenic responses independently of the majorhistocompatibility complex" 57 : 11-20, 2003.

30 Handgretinger R,, "Megadose transplantation of purified peripheral bloodCD34 progenitor cells from HLA-mismatched parental donorsin children" 27 : 777-783, 2001.

31 Prockop DJ, "Marrow Stromal cells as stem cells for nonhematopoietictissues" 276 : 71-74, 1997.

32 Hentschke P, "Low-intensity conditioning and hematopoieticstem cell transplantation in patients with renal and coloncarcinoma" 31 : 253-261, 2003.

33 Rolink AG, "Long-term in vivoreconstitiution of T-cell development by Pax5-deficient B-cellprogenitors" 401 : 603-606, 1999.

34 Soderdahl G, "Liver transplantation followed byadjuvant nonmyeloablative hemopoietic stem cell transplantationfor advanced primary liver cancer in humans" 75 : 1061-1066, 2003.

35 Sprent, "Intrathymic and extrathymic clonal deletion of Tcells" 7 : 196-205, 1995.

36 Salgar SK, "Infusion ofdonor leukocytes to induce tolerance in organ allograft recipients" 66 : 310-314, 1999.

37 Di Nicola M, "Human bone marrowstromal cells suppress T-lymphocyte proliferation induced bycellular or nonspecific mitogenic stimuli" 99 : 3838-3843, 2000.

38 Ricordi C, "High-dose donor bone marrowinfusions to enhance allograft survival the effect of timing" 63 : 7-11, 1997.

39 Alison MR, "Hepatocytesfrom non-hepatic adult stem cells" 406 : 257-, 2000.

40 Varadi G, "Graftversus-lymphoma effect after allogeneic peripheral blood stemcell transplantation for primary central nervous system lymphoma" 34 : 185-190, 1999.

41 Geiger H, "Globin gene expression isreprogrammed in chimeras generated by injecting adult hematopoieticstem cells into mouse blastocysts." 93 : 1055-1065, 1998.

42 Clark DL, "Generalized potential of adult neural stemcells" 288 : 1660-1663, 2000.

43 Tada M, "Embryonicgerm cells induce epigenetic reprogramming of somatic nucleus inhybrid cells" 16 : 6510-6520, 1997.

44 Gussoni E, "Dystrophin expreesion in the mdxmouse restored by stem cell transplantation" 401 : 390-394, 1999.

45 Hamano K, "Donormicrochimerism is not responsible for the maintenance of toleranceto donor alloantigens in recipients tolerant of cardiac allografts" 27 : 151-152, 1995.

46 Demetris AJ, "Donor dendritic cell repopulation in recipients afterrat-to-mouse bone-marrow transplantation" 1610-339 1611, 1992.

47 Starzl TE, "Chimerism anddonor-specific nonreactivity 27 to 29 years after kidney allotransplantation" 1272-55 1277, 1993.

48 Reyes M, "Characterization of multipotent adultprogenitor cells a subpopulation of mesenchymal stem cells" 938 : 231-233, 2001.

49 Ying QL, "Changing potency by spontaneous fusion" 416 : 545-548, 2002.

50 Kawada H, "Bone marrow origin of hematopoieticprogenitors and stem cells in murine muscle" 98 : 2008-2013, 2001.

51 Krampera M, "Bone marrow mesenchymal stem cells inhibit theresponse of naive and memory antigen-specific T cells to theircognate peptide" 101 : 3722-3729, 2002.

52 Terada N, "Bone marrow cellsadopt the phenotype of other cells by spontaneous cell fusion" 416 : 542-545, 2002.

53 Orlic D, "Bone marrow cells regenerate infarcted myocardium" 410 : 701-705, 2001.

54 Woodbury D, "Adult rat andhuman bone marrow stromal cells differentiate into neurons" 61 : 364-370, 2000.

55 Blackman MA, "A role for clonal inactivation in T celltolerance to Mls-1a." 540-345 542, 1990.

56 Pham SM, "A clinical trial combining donor bone marrow infusion and heart transplantation : intermediateterm results" 119 : 673-681, 2000.